(Q40213652)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17077357%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

title

Effects of intravenously administered recombinant vesicular stomatitis virus (VSV(deltaM51)) on multifocal and invasive gliomas (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17077357%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

XueQing Lun

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17077357%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Donna L Senger

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17077357%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Tommy Alain

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17077357%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Andra Oprea

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17077357%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Kelley Parato

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17077357%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Dave Stojdl

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17077357%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Brian Lichty

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17077357%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Anthony Power

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17077357%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Randal N Johnston

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17077357%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Mark Hamilton

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17077357%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Peter A Forsyth

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17077357%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

language of work or name

English

0 references

publication date

1 November 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17077357%20AND%20SRC:MED&resulttype=core&format=json

Journal of the National Cancer Institute

21 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17077357%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

98

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17077357%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17077357%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

1546-1557

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17077357%20AND%20SRC:MED&resulttype=core&format=json

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

Epidemiology and etiology of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

Current and future strategies for the treatment of malignant brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

Cost of Migration: Invasion of Malignant Gliomas and Implications for Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

Reovirus as an oncolytic agent against experimental human malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

Reovirus therapy of tumors with activated Ras pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

Systemic antitumor immunity in experimental brain tumor therapy using a multimutated, replication-competent herpes simplex virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

MTH-68/H oncolytic viral treatment in human high-grade gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

Intergeneric poliovirus recombinants for the treatment of malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

Treatment of intracerebral neoplasia and neoplastic meningitis with regional delivery of oncolytic recombinant poliovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

Myxoma virus is a novel oncolytic virus with significant antitumor activity against experimental human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

Oncolytic adenoviruses for malignant glioma therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

Replication and cytopathic effect of oncolytic vesicular stomatitis virus in hypoxic tumor cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

Oncolytic activity of vesicular stomatitis virus is effective against tumors exhibiting aberrant p53, Ras, or myc function and involves the induction of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

Efficient gene transfer of VSV-G pseudotyped retroviral vector to human brain tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

Armed therapeutic viruses: strategies and challenges to arming oncolytic viruses with therapeutic genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

Adenoviral vectors: systemic delivery and tumor targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

HSV1716 injection into the brain adjacent to tumour following surgical resection of high-grade glioma: safety data and long-term survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

The potential for efficacy of the modified (ICP 34.5(-)) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

Recent progress in the battle between oncolytic viruses and tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

Vesicular stomatitis virus as an oncolytic vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

Getting oncolytic virus therapies off the ground

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

Replication-selective virotherapy for cancer: Biological principles, risk management and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

Defective translational control facilitates vesicular stomatitis virus oncolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

Oncolytic herpes simplex virus vector therapy of breast cancer in C3(1)/SV40 T-antigen transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

Intra-arterial delivery of p53-containing adenoviral vector into experimental brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

Complement depletion facilitates the infection of multiple brain tumors by an intravascular, replication-conditional herpes simplex virus mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

Quantitation of HSV mass distribution in a rodent brain tumor model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

Tumor-specific intravenous gene delivery using oncolytic adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

Intravenous RMP-7 increases delivery of ganciclovir into rat brain tumors and enhances the effects of herpes simplex virus thymidine kinase gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

Systemic therapy of experimental breast cancer metastases by mutant vesicular stomatitis virus in immune-competent mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

Treatment of multi-focal colorectal carcinoma metastatic to the liver of immune-competent and syngeneic rats by hepatic artery infusion of oncolytic vesicular stomatitis virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

Efficacy and safety evaluation of human reovirus type 3 in immunocompetent animals: racine and nonhuman primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

Reovirus as an experimental therapeutic for brain and leptomeningeal metastases from breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

Migrating glioma cells activate the PI3-K pathway and display decreased susceptibility to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

Targeting human glioblastoma cells: comparison of nine viruses with oncolytic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

Quantitative estimates of vascularity in solid tumors by non-invasive near-infrared spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

Quantitative study of microvessel ultrastructure in human peritumoral brain tissue. Evidence for a blood-brain barrier defect

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

1995 Whitaker Lecture: delivery of molecules, particles, and cells to solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ413

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJJ413

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17077357%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference